Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.63 is 27% above its 5-year average of 5.22, around the middle of its 5-year range (1.88–9.74).
As of the fiscal period ended Tuesday, June 30, 2026. 7.68% below its 12-month average of 7.19.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.63.
CURRENT RATIO
6.63
CURRENT RATIO AVG TTM
7.19
CURRENT RATIO AVG 3Y
6.00
CURRENT RATIO AVG 5Y
5.22
CURRENT RATIO AVG 10Y
4.94
CURRENT RATIO AVG 15Y
3.69
CURRENT RATIO AVG 20Y
3.03
CURRENT VS TTM AVG
-7.68%
CURRENT VS 3Y AVG
+10.58%
CURRENT VS 5Y AVG
+27.13%
CURRENT VS 10Y AVG
+34.25%
CURRENT VS 15Y AVG
+79.68%
CURRENT VS 20Y AVG
+118.85%
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+76.92%
vs the sector median at left
Abeona Therapeutics Inc.
Market Cap
$285.55M
Current Ratio
6.63
TTM Avg
7.19
3Y Avg
6.00
5Y Avg
5.22
Market Cap
$285.42M
Current Ratio
45.02
TTM Avg
28.56
3Y Avg
20.10
5Y Avg
23.41
Market Cap
$281.54M
Current Ratio
31.35
TTM Avg
25.02
3Y Avg
20.04
5Y Avg
16.03
Market Cap
$288.79M
Current Ratio
4.70
TTM Avg
5.10
3Y Avg
7.75
5Y Avg
8.34
Market Cap
$280.37M
Current Ratio
4.69
TTM Avg
11.27
3Y Avg
11.27
5Y Avg
11.27
Market Cap
$293.30M
Current Ratio
19.48
TTM Avg
1.73
3Y Avg
4.11
5Y Avg
4.35
Market Cap
$292.59M
Current Ratio
13.28
TTM Avg
4.54
3Y Avg
4.54
5Y Avg
4.54
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | $285.55M | 6.63 | 7.19 | 6.00 | 5.22 |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | 5.36 | 5.13 | 3.92 | 3.90 |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | 45.02 | 28.56 | 20.10 | 23.41 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | 31.35 | 25.02 | 20.04 | 16.03 |
| Standard BioTools Inc. (LAB)vs › | $282.64M | 9.10 | 4.95 | 4.04 | 3.29 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | 4.70 | 5.10 | 7.75 | 8.34 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | 4.69 | 11.27 | 11.27 | 11.27 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | 19.48 | 1.73 | 4.11 | 4.35 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | 13.28 | 4.54 | 4.54 | 4.54 |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | 1.61 | 3.39 | 4.35 | 5.01 |
Current Ratio
6.63
Quick Ratio
6.40
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.63 |
| 2026-03-31 | 5.89 |
| 2025-12-31 | 6.93 |
| 2025-09-30 | 9.74 |
| 2025-06-30 | 6.73 |
| 2025-03-31 | 4.90 |
| 2024-12-31 | 6.08 |
| 2024-09-30 | 6.12 |
| 2024-06-30 | 7.48 |
| 2024-03-31 | 5.61 |
| 2023-12-31 | 4.15 |
| 2023-09-30 | 6.81 |
| 2023-06-30 | 4.67 |
| 2023-03-31 | 5.77 |
| 2022-12-31 | 6.83 |
| 2022-09-30 | 2.02 |
| 2022-06-30 | 2.21 |
| 2022-03-31 | 3.18 |
| 2021-12-31 | 3.39 |
| 2021-09-30 | 2.57 |
| 2021-06-30 | 1.88 |
| 2021-03-31 | 2.17 |
| 2020-12-31 | 2.33 |
| 2020-09-30 | 2.70 |
| 2020-06-30 | 2.90 |
| 2020-03-31 | 3.24 |
| 2019-12-31 | 3.42 |
| 2019-09-30 | 2.45 |
| 2019-06-30 | 2.54 |
| 2019-03-31 | 3.35 |
| 2018-12-31 | 4.37 |
| 2018-09-30 | 11.09 |
| 2018-06-30 | 21.07 |
| 2018-03-31 | 20.79 |
| 2017-12-31 | 25.07 |
| 2017-09-30 | 22.13 |
| 2017-06-30 | 14.05 |
| 2017-03-31 | 10.52 |
| 2016-12-31 | 8.37 |
| 2016-09-30 | 4.90 |
| 2016-06-30 | 3.98 |
| 2016-03-31 | 4.95 |
| 2015-12-31 | 27.47 |
| 2015-09-30 | 27.83 |
| 2015-06-30 | 16.13 |
| 2015-03-31 | 6.60 |
| 2014-12-31 | 3.99 |
| 2014-09-30 | 0.02 |
| 2014-06-30 | 0.02 |
| 2014-03-31 | 0.04 |
| 2013-12-31 | 0.06 |
| 2013-09-30 | 0.13 |
| 2013-06-30 | 0.30 |
| 2013-03-31 | 0.22 |
| 2012-12-31 | 0.25 |
| 2012-09-30 | 0.09 |
| 2012-06-30 | 0.14 |
| 2012-03-31 | 0.21 |
| 2011-12-31 | 0.27 |
| 2011-09-30 | 0.12 |
| 2011-06-30 | 0.35 |
| 2011-03-31 | 0.42 |
| 2010-12-31 | 0.57 |
| 2010-09-30 | 0.11 |
| 2010-06-30 | 0.35 |
| 2010-03-31 | 0.51 |
| 2009-12-31 | 0.08 |
| 2009-09-30 | 0.22 |
| 2009-06-30 | 0.18 |
| 2009-03-31 | 0.38 |
| 2008-12-31 | 0.39 |
| 2008-09-30 | 1.02 |
| 2008-06-30 | 1.72 |
| 2008-03-31 | 2.73 |
| 2007-12-31 | 4.03 |
| 2007-09-30 | 0.17 |
| 2007-06-30 | 0.19 |
| 2007-03-31 | 0.29 |
| 2006-12-31 | 0.47 |
| 2006-09-30 | 0.35 |
| 2006-06-30 | 0.42 |
| 2006-03-31 | 0.72 |
| 2005-12-31 | 1.35 |
| 2005-09-30 | 0.17 |
| 2005-06-30 | 0.19 |
| 2005-03-31 | 0.35 |
| 2004-12-31 | 0.30 |
| 2004-09-30 | 0.58 |
| 2004-06-30 | 2.63 |
| 2004-03-31 | 3.19 |
| 2003-12-31 | 1.33 |
| 2003-09-30 | 2.34 |
| 2003-06-30 | 2.55 |
| 2003-03-31 | 2.12 |
| 2002-12-31 | 2.59 |
| 2002-09-30 | 4.22 |
